Your browser doesn't support javascript.
loading
Clinical and prognostic impact of chronotropic incompetence in patients with hypertrophic cardiomyopathy.
Magri, Damiano; Agostoni, Piergiuseppe; Sinagra, Gianfranco; Re, Federica; Correale, Michele; Limongelli, Giuseppe; Zachara, Elisabetta; Mastromarino, Vittoria; Santolamazza, Caterina; Casenghi, Matteo; Pacileo, Giuseppe; Valente, Fabio; Morosin, Marco; Musumeci, Beatrice; Pagannone, Erika; Maruotti, Antonello; Uguccioni, Massimo; Volpe, Massimo; Autore, Camillo.
Afiliación
  • Magri D; Dpt Clinical and Molecular Medicine, Sapienza University, Rome, Italy. Electronic address: damiano.magri@uniroma1.it.
  • Agostoni P; Centro Cardiologico Monzino, IRCCS, Milano, Italy; Dpt of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
  • Sinagra G; Cardiovascular Dpt "Ospedali Riuniti" Trieste and Postgraduate School Cardiovascular Sciences, University of Trieste Cardiology Division, Italy.
  • Re F; Cardiac Arrhythmia Center and Cardiomyopathies Unit, San Camillo-Forlanini Hospital, Roma, Italy.
  • Correale M; Dpt of Cardiology, University of Foggia, Foggia, Italy.
  • Limongelli G; Cardiologia SUN, Monaldi Hospital, II University of Naples, Naples, Italy.
  • Zachara E; Cardiac Arrhythmia Center and Cardiomyopathies Unit, San Camillo-Forlanini Hospital, Roma, Italy.
  • Mastromarino V; Dpt Clinical and Molecular Medicine, Sapienza University, Rome, Italy.
  • Santolamazza C; Dpt Clinical and Molecular Medicine, Sapienza University, Rome, Italy.
  • Casenghi M; Dpt Clinical and Molecular Medicine, Sapienza University, Rome, Italy.
  • Pacileo G; Cardiologia SUN, Monaldi Hospital, II University of Naples, Naples, Italy.
  • Valente F; Cardiologia SUN, Monaldi Hospital, II University of Naples, Naples, Italy.
  • Morosin M; Cardiovascular Dpt "Ospedali Riuniti" Trieste and Postgraduate School Cardiovascular Sciences, University of Trieste Cardiology Division, Italy.
  • Musumeci B; Dpt Clinical and Molecular Medicine, Sapienza University, Rome, Italy.
  • Pagannone E; Dpt Clinical and Molecular Medicine, Sapienza University, Rome, Italy.
  • Maruotti A; Dpt of Scienze economiche, politiche e delle lingue moderne - Libera Università SS Maria Assunta, Rome, Italy; Centre for innovation and leadership in health sciences, University of Southampton, Southampton, UK.
  • Uguccioni M; Cardiac Arrhythmia Center and Cardiomyopathies Unit, San Camillo-Forlanini Hospital, Roma, Italy.
  • Volpe M; Dpt Clinical and Molecular Medicine, Sapienza University, Rome, Italy; IRCCS - Neuromed, Pozzilli, IS, Italy.
  • Autore C; Dpt Clinical and Molecular Medicine, Sapienza University, Rome, Italy.
Int J Cardiol ; 271: 125-131, 2018 Nov 15.
Article en En | MEDLINE | ID: mdl-30087038
BACKGROUND: A blunted heart rate (HR) response is associated with an impaired peak oxygen uptake (pVO2), a powerful outcome predictor in hypertrophic cardiomyopathy (HCM). The present multicenter study sought to determine the prognostic role for exercise-induced HR response in HCM. METHODS: A total of 681 consecutive HCM outpatients on optimized treatment were recruited. The heart failure (HF) end-point was death due to HF, cardiac transplantation, NYHA III-IV class progression, HF worsening leading to hospitalization and severe functional deterioration leading to septal reduction. The sudden cardiac death (SCD) end-point included SCD, aborted SCD and appropriate implantable cardioverter defibrillator discharges. RESULTS: During a median follow-up of 4.2 years (25-75th centile: 3.9-5.2), 81 patients reached the HF and 23 the SCD end-point. Covariates with independent effects on the HF end-point were left atrial diameter, left ventricular ejection fraction, maximal left ventricular outflow tract gradient and exercise cardiac power (ECP = pVO2∗systolic blood pressure) (C-Index = 0.807) whereas the HCM Risk-SCD score and the ECP remained associated with the SCD end-point (C-Index = 0.674). When the VO2-derived variables were not pursued, peak HR (pHR) re-entered in the multivariate HF model (C-Index = 0.777) and, marginally, in the SCD model (C-index = 0.656). A pHR = 70% of the maximum predicted resulted as the best cut-off value in predicting the HF-related events. CONCLUSIONS: The cardiopulmonary exercise test is pivotal in the HCM management, however the pHR remains a meaningful alternative parameter. A pHR < 70% identified a HCM population at high risk of HF-related events, thus calling for a reappraisal of the chronotropic incompetence threshold in HCM.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cardiomiopatía Hipertrófica / Frecuencia Cardíaca Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Cardiol Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cardiomiopatía Hipertrófica / Frecuencia Cardíaca Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Cardiol Año: 2018 Tipo del documento: Article